glp-1 receptor agonists in idiopathic intracranial hypertension and the Challenge of Weight Loss Can glucagon-like peptide-1 (GLP-1) receptor
Description
Cost effectiveness of sodium-glucose cotransporter-2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and dipeptidyl peptidase-4 (DPP-4) inhibitors: a systematic review
Diabetes, Obesity & Metabolism, 20 ,
Granata A, Maccarrone R, Anzaldi M, Leonardi G, Pesce F, Amico F, et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 140.Edison P, et al
